{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:42:40Z","timestamp":1784860960864,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bioorg.2021.105306","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T10:57:07Z","timestamp":1630061827000},"page":"105306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Discovery of a series of 5-phenyl-2-furan derivatives containing 1,3-thiazole moiety as potent Escherichia coli \u03b2-glucuronidase inhibitors"],"prefix":"10.1016","volume":"116","author":[{"given":"Tao-Shun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Lu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao-Qi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Biao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ning","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105306_b0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1089\/rej.2013.1407","article-title":"Human \u03b2-glucuronidase: structure, function, and application in enzyme replacement therapy","volume":"16","author":"Naz","year":"2013","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.bioorg.2021.105306_b0010","doi-asserted-by":"crossref","first-page":"e79687","DOI":"10.1371\/journal.pone.0079687","article-title":"High resolution crystal structure of human \u03b2-glucuronidase reveals structural basis of lysosome targeting","volume":"8","author":"Hassan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2021.105306_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128743","article-title":"\u03b2-glucuronidase inhibitors from Malaysian plants","volume":"1221","author":"Liew","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2021.105306_b0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1021\/acs.jnatprod.9b00279","article-title":"Isolation and structural characterization of specific bacterial \u03b2-glucuronidase inhibitors from noni (Morinda citrifolia) fruits","volume":"83","author":"Yang","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2021.105306_b0025","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(03)13780-4","article-title":"The camptothecins","volume":"361","author":"Pizzolato","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.bioorg.2021.105306_b0030","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s40265-017-0741-1","article-title":"Liposomal irinotecan: a review in metastatic pancreatic adenocarcinoma","volume":"77","author":"Lamb","year":"2017","journal-title":"Drugs."},{"key":"10.1016\/j.bioorg.2021.105306_b0035","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1200\/JCO.2012.48.5805","article-title":"Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial","volume":"31","author":"Hironaka","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2021.105306_b0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00280-010-1310-4","article-title":"Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of \u03b2-glucuronidase activity in intestinal lumen","volume":"67","author":"Kurita","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105306_b0045","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1126\/science.1191175","article-title":"Alleviating cancer drug toxicity by inhibiting a bacterial enzyme","volume":"330","author":"Wallace","year":"2010","journal-title":"Science."},{"key":"10.1016\/j.bioorg.2021.105306_b0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cbi.2018.06.018","article-title":"Impact of diet on irinotecan toxicity in mice","volume":"291","author":"Mallick","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2021.105306_b0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2036.1988.tb00771.x","article-title":"NSAIDs: a clinical approach to the problems of gastrointestinal side-effects","volume":"2","author":"Butt","year":"1988","journal-title":"Aliment. Pharm. Ther."},{"key":"10.1016\/j.bioorg.2021.105306_b0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11377-006-0033-x","article-title":"Gastrointestinal side-effects of non-steroidal anti-inflammatory drugs (NSAIDs)","volume":"1","author":"Bolten","year":"2006","journal-title":"Gastroenterologe."},{"key":"10.1016\/j.bioorg.2021.105306_b0065","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/17512433.2018.1516143","article-title":"NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs","volume":"11","author":"Garc\u00eda-Rayado","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105306_b0070","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1021\/acs.jmedchem.7b00963","article-title":"Specific inhibition of bacterial \u03b2-glucuronidase by pyrazolo[4,3-c]quinoline derivatives via a pH-dependent manner to suppress chemotherapy-induced intestinal toxicity","volume":"60","author":"Cheng","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105306_b0075","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/740815","article-title":"Discovery of specific inhibitors for intestinal E. coli \u03b2-glucuronidase through in silico virtual screening","volume":"2015","author":"Cheng","year":"2015","journal-title":"Sci. World J."},{"key":"10.1016\/j.bioorg.2021.105306_b0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jff.2018.07.013","article-title":"Prenylflavonoids sanggenon C and kuwanon G from mulberry (Morus alba L.) as potent broad-spectrum bacterial \u03b2-glucuronidase inhibitors: biological evaluation and molecular docking studies","volume":"48","author":"Wei","year":"2018","journal-title":"J. Funct. Foods."},{"key":"10.1016\/j.bioorg.2021.105306_b0085","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1080\/14756366.2020.1780225","article-title":"Cinnamic acid derivatives: inhibitory activity against Escherichia coli \u03b2-glucuronidase and structure-activity relationships","volume":"35","author":"Li","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105306_b0090","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1080\/14756366.2020.1816998","article-title":"Thiazolidin-2-cyanamides derivatives as novel potent Escherichia coli \u03b2-glucuronidase inhibitors and their structure-inhibitory activity relationships","volume":"35","author":"Zhou","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105306_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113322","article-title":"2,5-Disubstituted furan derivatives containing 1,3,4-thiadiazole moiety as potent \u03b1-glucosidase and E. coli \u03b2-glucuronidase inhibitors","volume":"216","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105306_b0100","doi-asserted-by":"crossref","first-page":"11867","DOI":"10.1021\/acs.jafc.9b04085","article-title":"Novel S-Thiazol-2-yl-furan-2-carbothioate derivatives as potential T3SS inhibitors against Xanthomonas oryzae on Rice","volume":"67","author":"Jiang","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2021.105306_b0105","article-title":"Synthesis and fungicidal activity of novel pyrazole derivatives containing 5-Phenyl-2-Furan","volume":"27","author":"Ahmeda","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105306_b0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bioorg.2017.01.015","article-title":"Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: as \u03b2-glucuronidase inhibitors","volume":"71","author":"Taha","year":"2017","journal-title":"Bioorgan. Chem."},{"key":"10.1016\/j.bioorg.2021.105306_b0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bioorg.2016.12.011","article-title":"Synthesis, in vitro \u03b2-glucuronidase inhibitory activity and in silico studies of novel (E)-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl) thiazoles","volume":"70","author":"Salar","year":"2017","journal-title":"Bioorgan. Chem."},{"key":"10.1016\/j.bioorg.2021.105306_b0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11030-013-9500-8","article-title":"Evaluation of the thiazole Schiff bases as \u03b2-glucuronidase inhibitors and their in silico studies","volume":"18","author":"Khan","year":"2014","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2021.105306_b0125","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/bjc.1957.71","article-title":"Enzyme activity in relation to cancer: inhibition of urinary \u03b2-glucuronidase of patients with cancer of the bladder by oral administration of 1:4-saccharolactone and related compounds","volume":"11","author":"Boyland","year":"1957","journal-title":"Brit. J. Cancer."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105306_b0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000458183","article-title":"\u03b2-glucuronidase activity in serum, cerebrospinal fluid and urine in normal subjects and in neurological and mental patients","volume":"8","author":"Plum","year":"1967","journal-title":"Enzym. Biol. Clin."},{"key":"10.1016\/j.bioorg.2021.105306_b0135","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1016\/j.bmc.2019.05.049","article-title":"Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent \u03b2-glucuronidase inhibitors and their molecular docking study","volume":"27","author":"Taha","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105306_b0140","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/1087057112444927","article-title":"Potential repurposing of known drugs as potent bacterial \u03b2-glucuronidase inhibitors","volume":"17","author":"Ahmad","year":"2012","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bioorg.2021.105306_b0145","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1158\/1078-0432.CCR-14-0395","article-title":"Old drug new use\u2014amoxapine and its metabolites as potent bacterial \u03b2-glucuronidase inhibitors for alleviating cancer drug toxicity","volume":"20","author":"Kong","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2021.105306_b0150","doi-asserted-by":"crossref","first-page":"e39764","DOI":"10.1371\/journal.pone.0039764","article-title":"Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS ONE."},{"key":"10.1016\/j.bioorg.2021.105306_b0155","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2613.2009.00671.x","article-title":"Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile","volume":"90","author":"Stringer","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bioorg.2021.105306_b0160","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1073\/pnas.1918095117","article-title":"Targeted inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy","volume":"117","author":"Bhatt","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioorg.2021.105306_b0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pestbp.2019.07.005","article-title":"Synthesis and biological evaluation of 1,3,4-thiadiazole derivatives as type III secretion system inhibitors against Xanthomonas oryzae","volume":"160","author":"Tao","year":"2019","journal-title":"Pestic. Biochem. Phys."},{"key":"10.1016\/j.bioorg.2021.105306_b0170","doi-asserted-by":"crossref","first-page":"20204","DOI":"10.1038\/srep20204","article-title":"Synthesis and fungicidal activity of novel 2,5-disubstituted-1,3,4- thiadiazole derivatives containing 5-phenyl-2-furan","volume":"6","author":"Cui","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2021.105306_b0175","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1007\/s00253-018-9285-x","article-title":"Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing \u03b2-glucuronidase from Staphylococcus pasteuri 3I10","volume":"102","author":"Wei","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioorg.2021.105306_b0180","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3109\/14756360902829766","article-title":"A graphical method for determining inhibition constants","volume":"24","author":"Yoshino","year":"2009","journal-title":"J. Enzyme Inhib. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821006830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821006830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:26:56Z","timestamp":1758616016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821006830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":36,"alternative-id":["S0045206821006830"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105306","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a series of 5-phenyl-2-furan derivatives containing 1,3-thiazole moiety as potent Escherichia coli \u03b2-glucuronidase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105306"}}